BCRX is an emerging biotech–pharmaceutical stock with several promising drugs in the pipeline. It is hard to say which of BioCryst Pharmaceuticals 3 drugs will be the first or best candidate to generously reward stockholders. With Trial results from 2 leading candidates expected to be released in the next few months and flu season around the corner stockholders of BCRX are entering an exciting and potentially very profitable time.For an in depth report on BCRX stock visit http://www.stocktipweekly.com/ where stock market traders and investors benefit from the research and experience of the STW analysts.
The stock analysts at STW isolate emerging & small cap stocks focusing on the biotech and pharmaceutical sectors. Each week they feature one stock recommendation that analysis shows has good upside potential for a swing trade or long term profits. The STW stock picks are chosen on several factors including current company news, FDA trials, technical analysis and general market trends to help traders and investors select the best share price entry and timing. Always do your own their own due diligence before deciding to take a position in any investment.